Fact CheckerSign in

NCT04746157Completed

A Nursing Support Intervention-based Project for Stroke Survivors

A Nursing Support Intervention-based Project for Stroke Survivors to Improve Patient Centered Outcomes Measures

Source: ClinicalTrials.gov · Last updated 15 Mar 2024

Brief summary (registry, in English)

Stroke is the second single most common cause of death and the main cause of disability in the European Union (EU) region. Stroke victims face an uncertain future and a life severely affected by disability. Although there have been many advances in scientific knowledge and innovation in stroke research, improvements in stroke systems of care are still necessary to ensure patient outcomes and improve their quality of life after stroke. The main goal of PROICTUS program ("pro" in Greek means before and in Latin means forward movement) is to evaluate a nursing support intervention to improve PROMS (patient reported outcome measures) and the quality of life in stroke survivors. Patients will have a directly contact with the lead nurse by telephone, so they will receive information about their disease, their current situation given them a personalized care and resolving questions that are important for them in their new life situation

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
18 Dec 2020
Start date
15 Mar 2021
Primary completion date
31 Dec 2023
Lead sponsor
Institut de Recerca Biomèdica de Lleida
Diseases
Stroke
NCT number
NCT04746157

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 15 Mar 2021 to the primary completion date, 31 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Advanced medical comorbidity (eg. dementia affecting basic activities of daily living, cancer, HIV, Hep B or C)
  • Cognitive impairment

Other

  • Isolated sensory symptoms
  • Aphasia
  • Hearing loss
  • Taking part in another study

Who the study is looking for

  • Ischaemic stroke or haemorrhagic stroke and NIHSS ≤ 5
  • TIA with motor, speech or visual impairment
  • Premorbid mRS\<4
  • Event onset later than 72hr but within 14 days
  • Medically-stable
  • Consent-capable

Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRBLleida
Coordinator of this site? Confirm its status
LleidaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.